alexa
Reach Us +1-217-403-9671
Bioprocess Development For Production Of Biopharmaceuticals From Plant Origin | 7393
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Bioprocess development for production of biopharmaceuticals from plant origin

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Prasad A. Wadegaonkar and Varsha P. Wadegaonkar

ScientificTracks Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.002

Abstract
The recent years have witnessed revival of interest in herbal medicine as more and more people throughout world are turning to use medicinal plant products in healthcare. WHO currently encourages, recommends and promotes traditional herbal remedies in national healthcare programmes. In modern times the issues of quality, safety and efficacy of medicines are interrelated. The quality of drug is of supreme importance as it can affect the issues of efficacy and safety. There are always changes of wide variations with respect to their chemical contents in crude drugs/ raw materials of plant origin due to various reasons such as climate, geographic distribution, source and season of collection etc. Bioprocess engineering has played a successful role in developing and producing pharmaceuticals from fungal and bacterial origin. The principles of this technology have already been exploited for commercial production of vaccines and therapeutic proteins from animal origin. The potential and knowledge of Bioprocess engineering has not yet fully exploited for commercial production of biopharmaceuticals from herbal origin. Scale up of suspension cultures, tissue and organ cultures of medicinal plants can overcome most of the shortcomings of herbal medicines obtained from natural resources. This approach also helps to understand and modulate the pathway for production of desired bioactive compounds in vitro.
Biography
Prasad A. Wadegaonkar has done post graduation in Biotechnology from M.S. University Baroda and Ph.D. from R.S.U. Raipur. He has worked as Production Manager at Bharat Immunologicals and Biologicals Corp. Ltd. At present he is working as Associate Professor in Biotechnology at Sant Gade Baba Amravati University. He has setup Bioprocess Laboratory at Sant Gadge Baba Amravati University for integration of plant cell culture, animal cell culture and bacterial system. He has also established Bioinformatics Infrastructure Facility under BTISNet of DBT, Govt. of India.
Top